BioVie Inc.
Price Action
Technical Summary
EMERGING TRENDBioVie Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is leading (RS Rating: 84), indicating clear outperformance against the broad market. Earnings growth of 53% provides fundamental context to the price action. However, price is extended 22% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $1.72 | +12.95% | ABOVE |
| 50 SMA | $1.58 | +22.49% | ABOVE |
| 100 SMA | $1.46 | +33.19% | ABOVE |
| 150 SMA | $1.42 | +36.74% | ABOVE |
| 200 SMA | $1.51 | +28.12% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is BIVI in an uptrend right now?
BIVI has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is BIVI overbought or oversold?
BIVI's RSI (14) is 56. The stock is in neutral territory, neither overbought nor oversold.
Is BIVI outperforming the market?
BIVI has a Relative Strength (RS) Rating of 84 out of 99. Yes, BIVI is a market leader, outperforming 84% of all stocks over the past 12 months.
Where is BIVI in its 52-week range?
BIVI is trading at $1.94, which is 19% of its 52-week high ($10.30) and 10% above its 52-week low ($1.06).
How volatile is BIVI?
BIVI has a Beta of 1.33 and 52-week volatility of 95%. It's more volatile than the S&P 500 - expect bigger swings.